associated with 4 other trademarks
Pharmaceuticals for the treatment of neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, hun...

Words that describe this trademark:

neuromuscular disease  neurodegenerative disease  disease genetic  alzheimers disease  genetic disorder  disease parkinsons  disease alzheimers  treatment  pharmaceuticals  disorder 

Serial Number:

97335452

Mark:

Status:

Abandoned-Express

Status Date:

01-16-2023

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceuticals for the treatment of neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; drug delivery agents in the form of capsules, granules, liquids, transdermal systems(patches), pellets, pills, powders, solutions, suspensions or tablets that facilitate the delivery of pharmaceutical preparations; medicated skin care preparations Medical laboratories; clinical research in the field of medicine for the treatment of neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder

Mark Description:

The mark consists of vertical wavy line in between triangle and horizontal prolate spheroid.

Class:

Scientific and technological services

Type of Mark:

Trademark

Published for Opposition Date:

N/A

Mark Drawing Status:

Design Only

Abandon Date:

01-13-2023

Business Name:

LADAS & PARRY LLP

Correspondent Name:

Recent Trademark filings by this company